| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.05 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.079 | 0.05 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.05 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.05 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.05 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.05 |